Significance of epidermal growth factor receptor in advanced ovarian cancer

Journal of Clinical Oncology

Volumn 10, Issue 4, 1992, Pages 529-535

  Scambia, Giovanni ^a   Panici, Pierluigi Benedetti ^a   Battaglia, Francesco ^a   Ferrandina, Gabriella ^a   Baiocchi, Gabriela ^a   Greggi, Stefano ^a   De Vincenzo, Rosa ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLLITROPIN; GONADORELIN; GROWTH HORMONE; INSULIN; PROTIRELIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIORECEPTOR ASSAY; RECEPTOR BINDING; RISK ASSESSMENT; SCATCHARD PLOT; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; FEMALE; HUMAN; IODINE RADIOISOTOPES; LIFE TABLES; MIDDLE AGE; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0026517954     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.4.529     Document Type: Article

References (21)

1. Ozols RF, Young RC: Chemotherapy of ovarian cancer. Semin Oncol 11:251-263, 1984
2. Dembo AJ, Bush RS: Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys 8:893-897, 1982
3. Malkasian GD, Melton LJ, O'Brien PC, et al: Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Ostet Gynecol 149:274-282, 1984
4. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56:881-884, 1987
5. Downward J, Yarden Y, Mayes E, et al: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521-527, 1984
6. Sainsbury JRC, Farndon JR, Needham JK, et al: Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398-1401, 1987
7. Battaglia F, Scambia G, Rossi S, et al: Epidermal growth factor receptor in human breast cancer: Correlation with steroid hormone receptors and axillary lymph-node involvement. Eur J Cancer Clin Oncol 24:1685-1690, 1988
8. Neal DE, Marsh C, Bennet MK, et al: Epidermal growth factor receptors in human bladder cancer: Comparison of invasive and superficial tumors. Lancet 1:366-368, 1985
9. Ozawa S, Ueda M, Ando N, et al: Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 63:2169-2173, 1989
10. Pfeiffer D, Stellwag B, Pfeiffer A, et al: Clinical implications of epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 3:146-150, 1989
11. Battaglia F, Scambia G, Benedetti Panici P, et al: Epidermal growth factor receptors in gynecological malignancies. Gynecol Obstet Invest 27:42-44, 1989
12. Gullick WJ, Marsden JJ, Whittle N, et al: Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 46:285-292, 1986
13. Bauknecht T, Runge M, Schwall M, et al: Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol Oncol 29:147-157, 1988
14. Berchuck A, Rodriguez GC, Kamel A, et al: Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol 164:669-674, 1991
15. Berchuck A, Olt GJ, Everitt L, et al: The role of peptide growth factors in epithelial ovarian cancer. Obstet Gynecol 75:255-262, 1990
16. Scambia G, Benedetti Panici P, Battaglia F, et al: Presence of epidermal growth factor (EGF) receptor and proliferative response to EGF in six human ovarian carcinoma cell lines. Int J Gynecol Cancer (in press)
17. International Federation of Gynecology and Obstetrics: Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156:263-264, 1987
18. Serov SF, Scully RE: Histological typing of ovarian tumors, in International Histological Classification of Tumors, no. 9. Geneva, Switzerland, World Health Organization, 1973
19. 2) cisplatin-induced neurotoxicity in primary advanced ovarian cancer patients. Cancer Treat Rep 71:669-670, 1987
20. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment, no. 48. Geneva, Switzerland, WHO 1979, pp 16-21
21. Benedetti Panici P, Scambia G, Greggi S, et al: Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look. Cancer Treat Rev 16:123-127, 1988